We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Sentinel Diagnostics

Sentinel Diagnostics develops and manufactures in-vitro diagnostic medical devices for routine analysis and specific ... read more Featured Products: More products

Download Mobile App





Sentinel Diagnostics Presents Latest Breakthroughs in Diagnostics

By LabMedica International staff writers
Posted on 12 Nov 2024
Print article
Image
Image

Sentinel Diagnostics (Milano, Italy) is sharing its latest breakthroughs in medical diagnostics at MEDICA 2024. The company is also hosting exciting presentations on molecular diagnostics, fecal immunochemical testing (FIT), chromatography, and lateral flow tests.

At this year’s MEDICA, Sentinel is showcasing is wide portfolio of compatible freeze-dried kits based on its proprietary STAT-NAT (Stabilized Amplification Technology) technology that has been developed with a new protective compound able to stabilize the activity of enzymes for a very long time with no temperature-controlled storage requirements. STAT-NAT technology yields very good performances in all the most diffused molecular biology techniques. It can improve test sensitivity even with low-concentrated DNA samples and contains all the reaction components. Sentinel is also highlighting its lyophilized STAT-NAT kits for various application areas such as virology, healthcare-associated infections, parasitology, and respiratory infections.

Designed to work with the lyophilized kits is Sentinel’s SENTiNAT 200 molecular diagnostics system that contains everything needed to perform a complete PCR analysis- rom sample extraction to Real-Time PCR results interpretation. The fully automated multiparametric system for pathogens detection can perform a multiparametric analysis on different matrices from one or more patients, using the same extraction and amplification protocol. Smart software takes care of every step of the process from sample loading to the result analysis with visual and simple terms to avoid any human errors.

At MEDICA 2024, Sentinel is also highlighting FOBGold line, its complete line for fecal occult blood testing (FIT). This includes the SENTiFIT 270 high-speed FIT system with a throughput of up to 270 tests per hour and featuring a patented pierceable tube for high-volume CRC screening. Also being showcased is the SENTiFOB automated FIT system with a throughput of up to tests per and compatible with pierceable tubes. In addition, Sentinel is highlighting the CALiaGold quantitative latex immunoassay for fecal calprotectin measurement as a marker of intestinal inflammation. The CALiaGold solution, together with the SENTiFIT 270 and SENTiFOB automated analyzers, offers a specific diagnostic system to differentiate IBD (Inflammatory Bowel Disease) from IBS (Irritable Bowel Syndrome). Visitors to the Sentinel booth can also learn more about the FOB Gold system which comprises a unique “2 in 1” tube for sample collection and a new generation immunological latex reagent for the determination of FOB.

Related Links:
Sentinel Diagnostics 

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centrifuge
Hematocrit Centrifuge 7511M4
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Total 25-Hydroxyvitamin D₂ & D₃ Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The study validated the Lumipulse p-tau21 automated and scalable blood test system (Photo courtesy of Fujirebio)

Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy

Alzheimer's disease (AD) is a debilitating condition and a leading cause of disability and death worldwide. The availability of reliable diagnostic tools is currently restricted, and diagnosis often relies... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.